CD99r as marker for alpha and beta cells
CA3318852A1Pending Publication Date: 2025-08-21LANNER BIOLOGICS AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3318852
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-02-13
- Filing Date
- 2025-02-11
- Publication Date
- 2025-08-21
Abstract
A method for enriching glucagon producing alpha cells and / or insulin producing beta cells in a mixture of cells, comprising labelling the cell surface marker CD99R in a starting mixture of cells with a label and separating the cells that are positive for the cell surface marker from cells that are negative for the cell surface marker to obtain a final mixture of cells that is more enriched in alpha cells and / or beta cells compared to the starting mixture. A use of an antibody specific for CD99R for detecting glucagon producing alpha cells and / or insulin producing beta cells.
Need to check novelty before this filing date? Find Prior Art